News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/Screenshot_4.png)
VIDEO: HPV testing predicted to displace most Pap smears
- Author:
- Mary Jo Dales
Publish date: April 30, 2014
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
VIDEO: Dr. Rosanne Kho: Selecting patients for minimally invasive vaginal surgery.
- Author:
- Mary Jo Dales
Publish date: April 29, 2014
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
VIDEO: Contraception 2014: What you need to know
- Author:
- Mary Jo Dales
Publish date: April 29, 2014
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/ACOG_screenshot.png)
ACOG President Dr. Jeanne A. Conry interviews Dr. Leslie Regan and Dr. Mark Hanson
- Author:
- Mary Jo Dales
Publish date: April 29, 2014
News
Ethnic differences in stem cell transplants may be narrowing
- Author:
- Mary Jo Dales
Publish date: December 7, 2013
Major finding: Just 20% of non-white patients in the study had a fully-matched donor available, while 69% of white northern European patients did...
Article
PD-L1 blockers take center stage at ASCO 2013
- Author:
- Mary Jo Dales
- Susan London
- Patrice Wendling
Publish date: September 4, 2013
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/finn_screenshot.png)
Palbociclib continues on fast track to potential FDA approval
- Author:
- Mary Jo Dales
Publish date: June 3, 2013
News
New data on Radium 223 presented at ASCO
- Author:
- Mary Jo Dales
Publish date: June 2, 2013
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/media_n7r1qt5p_95299.pho.jpg.jpg)
Nivolumab activity is durable in advanced melanoma
- Author:
- Mary Jo Dales
Publish date: June 2, 2013
Major finding: Median overall survival across all doses of nivolumab was 16.8 months.
News
Sorafenib extends survival in differentiated thyroid cancer
- Author:
- Mary Jo Dales
Publish date: June 2, 2013
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Treating refractory and metastatic lung cancer
- Author:
- Mary Jo Dales
Publish date: June 2, 2013
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/media_hfdgb8z7_Hodi_Stephen_F_Jr.jpg.jpg)
Adding GM-CSF to ipilimumab extends survival in metastatic melanoma
- Author:
- Mary Jo Dales
Publish date: June 2, 2013
Major finding: One year after the start of therapy, 69% of patients given the combination therapy and 53% of those who got ipilimumab alone were...
News
Melanoma advances make chemo third-tier therapy
- Author:
- Mary Jo Dales
Publish date: June 1, 2013
News
CMS proposes to expand antiemetogenic coverage
- Author:
- Mary Jo Dales
Publish date: March 20, 2013
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/September-2017/media_z5mg4qjc_FDA_icon.jpg.jpg)
Imaging agent approved for locating lymph nodes
- Author:
- Mary Jo Dales
Publish date: March 14, 2013